Back to top
more

McKesson (MCK)

(Real Time Quote from BATS)

$610.59 USD

610.59
1,634,064

+61.28 (11.16%)

Updated Nov 7, 2024 03:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

The Zacks Analyst Blog Highlights McKesson, AmerisourceBergen, LHC Group and Glaukos

by Zacks Equity Research

McKesson, AmerisourceBergen, LHC Group and Glaukos are part of Zacks top Analyst Blog.

Indrajit Bandyopadhyay headshot

Medical Device Stocks' Earnings on Aug 3: MCK, ABC & More

by Indrajit Bandyopadhyay

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how MCK, ABC, LHCG and GKOS fare this time.

McKesson (MCK) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

McKesson's (MCK) fiscal first-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.

McKesson (MCK) Gains But Lags Market: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $340.12, moving +0.15% from the previous trading session.

Analysts Estimate Becton Dickinson (BDX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Align Technology (ALGN) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Align Technology (ALGN) delivered earnings and revenue surprises of -5.66% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate McKesson (MCK) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

McKesson (MCK) Gains As Market Dips: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $330.44, moving +0.8% from the previous trading session.

Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXG

McKesson (MCK) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, McKesson (MCK) closed at $327.81, marking a +0.37% move from the previous day.

Here's Why You Should Hold on to OPKO Health (OPK) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and a few strategic agreements.

Potbelly's and Rio Tinto have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Potbelly's and Rio Tinto have been highlighted as Zacks Bull and Bear of the Day.

Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?

by Zacks Equity Research

Sector ETF report for FXG

QIAGEN (QGEN) QCI's Robust Adoption to Enhance Patient Outcome

by Zacks Equity Research

QIAGEN's (QGEN) QCI platform is expected to significantly streamline NGS data analysis and variant interpretation, and enable swift and confident shift by users from raw NGS data to clinical report.

Indrajit Bandyopadhyay headshot

3 Medical Device Stocks With Potential to Fight Recession Risk

by Indrajit Bandyopadhyay

The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volatility risks going forward.

NextGen (NXGN)-InstaMed Ink Deal to Improve Payment Processing

by Zacks Equity Research

NextGen's (NXGN) latest expanded deal with InstaMed is expected to significantly simplify payment methods for both patients and providers.

3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio

by Zacks Equity Research

Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care.

Reasons to Retain Surmodics (SRDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.

Alcon's (ALC) Product Launches, Market Recovery Aid Growth

by Zacks Equity Research

Despite bearing the brunt of inflationary pressure across both Total Surgical and Vision Care franchises, Alcon (ALC) succeeds in mitigating much of the impact through cost-improvement efforts.

McKesson (MCK) Gains But Lags Market: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed at $330 in the latest trading session, marking a +1.08% move from the prior day.

3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.

Has McKesson (MCK) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how McKesson (MCK) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.

Zacks Value Trader Highlights: H&R Block, McKesson, Stride, TransAlta and Murphy USA

by Zacks Equity Research

H&R Block, McKesson, Stride, TransAlta and Murphy USA are part of Zacks Value Trader blog.

Tracey Ryniec headshot

5 Value Stocks Near Their 52-Week Highs

by Tracey Ryniec

Not every stock is selling off in 2022. Here are 5 cheap stocks with high Zacks Rank trading near their 52-week highs.